American Peptide Company appoints two

Reflects ongoing commitment to provide better customer support

American Peptide Company, a US manufacturer of peptides and peptide-based services to the pharmaceutical and life science industries, has promoted Stewart Hamilton, who has its European sales representative since 2005, to sales and marketing director for the region.

In addition, Stuart White has joined the company as its US East Coast sales executive. White was most recently principal at Actif Bioresources, where he created supply networks dealing in products for therapeutic, mechanistic and academic studies.

‘The new appointments reflect the American Peptide Company’s ongoing commitment to providing better customer support and technical expertise to customers globally, helping them bring new drugs to market faster,’ said Takahiro Ogata, president and coo of American Peptide Company.

In December 2009, the company took on five new members of staff to enhance its technical capabilities.

You may also like

Ingredients

Bachem acquires American Peptide Company

No financial details have been disclosed
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

CPPs: beating drug delivery barriers

Cell-penetrating peptides are a promising tool for cellular import of drug cargos and have been applied in the delivery of a variety of therapeutic molecules. Jyothi Thundimadathil and Archana Gangakhedkar, American Peptide Co, highlight recent application studies
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Bicyclic peptides for a new class of targeted drugs

Bicyclic peptides are an emerging class of molecules used to explore new cellular sites not treatable using small molecules or large antibodies. Archana Gangakhedkar, American Peptide Company, reveals some of the properties that offer a new route to targeting diseases
Manufacturing

American Peptide to expand manufacturing capacity at Vista

Move will enable APC to process large-scale peptide production and meet cGMP standards
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Ingredients

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies
Ingredients

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene
Subscribe now